4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-039911
Chief Executive Officer returned 4,322 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virnich Daniel Chief Executive Officer | 2023-11-21 | Returned to the company | −4,322 | $2.19 | $9,478 | 729,603 | D |
Loading xslF345X05/wk-form4_1700704014.xml…